These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37515828)

  • 1. Reduction of nicotine and ethanol intake in alcohol-preferring (UChB) female rats by the α4β2 nicotinic acetylcholine receptor partial agonists 5-bromocytisine and cytisine.
    Quintanilla ME; Rivera-Meza M; Berríos-Cárcamo P; Cassels BK
    Drug Alcohol Depend; 2023 Sep; 250():110900. PubMed ID: 37515828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo modulation of dopaminergic nigrostriatal pathways by cytisine derivatives: implications for Parkinson's Disease.
    Abin-Carriquiry JA; Costa G; Urbanavicius J; Cassels BK; Rebolledo-Fuentes M; Wonnacott S; Dajas F
    Eur J Pharmacol; 2008 Jul; 589(1-3):80-4. PubMed ID: 18589414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varenicline and cytisine: two nicotinic acetylcholine receptor ligands reduce ethanol intake in University of Chile bibulous rats.
    Sotomayor-Zárate R; Gysling K; Busto UE; Cassels BK; Tampier L; Quintanilla ME
    Psychopharmacology (Berl); 2013 May; 227(2):287-98. PubMed ID: 23344555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological characterization of nicotinic acetylcholine receptors in cat petrosal ganglion neurons in culture: effects of cytisine and its bromo derivatives.
    Varas R; Valdés V; Iturriaga-Vásquez P; Cassels BK; Iturriaga R; Alcayaga J
    Brain Res; 2006 Feb; 1072(1):72-8. PubMed ID: 16406013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.
    Sala M; Braida D; Pucci L; Manfredi I; Marks MJ; Wageman CR; Grady SR; Loi B; Fucile S; Fasoli F; Zoli M; Tasso B; Sparatore F; Clementi F; Gotti C
    Br J Pharmacol; 2013 Feb; 168(4):835-49. PubMed ID: 22957729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the nicotinic agonist varenicline, nicotinic antagonist r-bPiDI, and DAT inhibitor (R)-modafinil on co-use of ethanol and nicotine in female P rats.
    Maggio SE; Saunders MA; Baxter TA; Nixon K; Prendergast MA; Zheng G; Crooks P; Dwoskin LP; Slack RD; Newman AH; Bell RL; Bardo MT
    Psychopharmacology (Berl); 2018 May; 235(5):1439-1453. PubMed ID: 29455292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
    Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of agonist and antagonist activities of α4β2* nAChR ligands to smoking cessation efficacy: a quantitative analysis of literature data.
    Rollema H; Hurst RS
    Psychopharmacology (Berl); 2018 Sep; 235(9):2479-2505. PubMed ID: 29980822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
    Cunningham CS; McMahon LR
    Eur J Pharmacol; 2011 Mar; 654(1):47-52. PubMed ID: 21172344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice.
    Hendrickson LM; Zhao-Shea R; Tapper AR
    Psychopharmacology (Berl); 2009 Jul; 204(4):563-72. PubMed ID: 19247637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal nicotinic receptor ligands modulate chronic nicotine-induced ethanol consumption in C57BL/6J mice.
    Sajja RK; Rahman S
    Pharmacol Biochem Behav; 2012 Jul; 102(1):36-43. PubMed ID: 22741175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Rezvani AH; Slade S; Wells C; Petro A; Lumeng L; Li TK; Xiao Y; Brown ML; Paige MA; McDowell BE; Rose JE; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2010 Aug; 211(2):161-74. PubMed ID: 20535453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule.
    Peng C; Stokes C; Mineur YS; Picciotto MR; Tian C; Eibl C; Tomassoli I; Guendisch D; Papke RL
    J Pharmacol Exp Ther; 2013 Nov; 347(2):424-37. PubMed ID: 23959137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
    Bito-Onon JJ; Simms JA; Chatterjee S; Holgate J; Bartlett SE
    Addict Biol; 2011 Jul; 16(3):440-9. PubMed ID: 21392178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotinic receptor partial agonists alter catecholamine homeostasis and response to nicotine in PC12 cells.
    Turcanu DS; Kirtok N; Eibl C; Guendisch D; LaGamma EF; Nankova BB
    Neurosci Lett; 2012 May; 516(2):212-6. PubMed ID: 22503726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus properties of the nicotinic agonist cytisine.
    Chandler CJ; Stolerman IP
    Psychopharmacology (Berl); 1997 Feb; 129(3):257-64. PubMed ID: 9084064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intra-accumbal administration of the nicotinic acetylcholine receptor agonist cytisine on the operant oral self-administration of ethanol were prevented by the GABAB receptor agonist baclofen in rats.
    Jiménez JC; Cortés-Salazar F; Ruiz-García RI; Hernández D; Miranda F
    Pharmacol Biochem Behav; 2024 Nov; 244():173850. PubMed ID: 39159761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
    Papke RL; Trocmé-Thibierge C; Guendisch D; Al Rubaiy SA; Bloom SA
    J Pharmacol Exp Ther; 2011 May; 337(2):367-79. PubMed ID: 21285282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y; Saito K; Imoto M; Ohno T
    Eur J Pharmacol; 1998 Jun; 351(2):181-8. PubMed ID: 9687001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist and antagonist effects of cytisine in vivo.
    Radchenko EV; Dravolina OA; Bespalov AY
    Neuropharmacology; 2015 Aug; 95():206-14. PubMed ID: 25839895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.